ARCHIVES

PCORI Approves $54.8 Million For Clinical Effectiveness Research

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Opens Advisory Committee Consideration Of NDAs, Finds Discussion Is Not Inhibited

September 10, 1976

Tyrosine Kinase Inhibitor Encoraging For NSCLC

July 27, 2001

Pitt Inquiry Panel Proceedings Suspended, ORI To Take Over NSABP Investigation

July 22, 1994

Study Supports Hypothesis On Mastectomy Timing

June 7, 1991

NCAB Gives President Evidence Supporting Limits On Tar, Nicotine

November 29, 1974

Breast Cancer Coalition Demonstrations Crucial To Obtaining Windfall

October 16, 1992